Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASEFY 2024 net sales[1] of USD 10.4 billion, up by 9%[2] in ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Key biosimilar value driver contributes to Sandoz global growth strategy and moves company closer to becoming #1 in ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Basel, February 24, 2025 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, announces the ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE FY 2024 net sales[1] of USD 10.4 billion, up by 9%[2] in constant currencies (+7% in USD); Q4 net sales of ...

Finance Minister Thangam Thennarasu on Friday (March 14, 2025) said to boost tourist arrivals in south Tamil Nadu and promote ...

The initiative aims to boost tourism in South Tamil Nadu and contribute to the economic development of the region ...

Q4 2024 Earnings Call Transcript February 28, 2025 Amneal Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

up by 5% in c Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Key biosimilar value driver contributes to Sandoz global growth strategy and moves company closer to becoming ...

For patients, biosimilars improve the affordability of ... As part of this collaboration, we will build two state-of-the-art manufacturing facilities, one for peptide drug substance production ...

Pharma sector is at a tipping point, with potential to become a global leader through agile, efficient, and sustainable ...